{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:32Z","timestamp":1740106952164,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00277-023-05484-z","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:01:55Z","timestamp":1696237315000},"page":"351-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-1068","authenticated-orcid":false,"given":"Nicola","family":"Sgherza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Curci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Perfetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela M. V.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Chironna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Tafuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"issue":"26","key":"5484_CR1","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1182\/blood.2020008150","volume":"136","author":"A Chari","year":"2020","unstructured":"Chari A, Samur MK, Martinez-Lopez J, Cook G, Biran N, Yong K, Hungria V, Engelhardt M, Gay F, Garc\u00eda Feria A, Oliva S, Oostvogels R, Gozzetti A, Rosenbaum C, Kumar S, Stadtmauer EA, Einsele H, Beksac M, Weisel K et al (2020) Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood 136(26):3033\u20133040. https:\/\/doi.org\/10.1182\/blood.2020008150","journal-title":"Blood"},{"issue":"12","key":"5484_CR2","doi-asserted-by":"publisher","first-page":"e934","DOI":"10.1016\/S2352-3026(21)00278-7","volume":"8","author":"H Ludwig","year":"2021","unstructured":"Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, Moreau P, Cavo M, Pawlyn C, Zweegman S, Engelhardt M, Driessen C, Cook G, Dimopoulos MA, Gay F, Einsele H, Delforge M, Caers J et al (2021) COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Lancet Haematol 8(12):e934\u2013e946. https:\/\/doi.org\/10.1016\/S2352-3026(21)00278-7","journal-title":"Lancet Haematol"},{"issue":"24","key":"5484_CR3","doi-asserted-by":"publisher","first-page":"6198","DOI":"10.1182\/bloodadvances.2022008530","volume":"6","author":"N Chuleerarux","year":"2022","unstructured":"Chuleerarux N, Manothummetha K, Moonla C, Sanguankeo A, Kates OS, Hirankarn N, Phongkhun K, Thanakitcharu J, Leksuwankun S, Meejun T, Thongkam A, Mongkolkaew T, Dioverti MV, Torvorapanit P, Langsiri N, Worasilchai N, Plongla R, Chindamporn A, Gopinath S et al (2022) Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis. Blood Adv 6(24):6198\u20136207. https:\/\/doi.org\/10.1182\/bloodadvances.2022008530","journal-title":"Blood Adv"},{"issue":"8","key":"5484_CR4","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.ccell.2021.06.014","volume":"39","author":"O Van Oekelen","year":"2021","unstructured":"Van Oekelen O, Gleason CR, Agte S, Srivastava K, Beach KF, Aleman A, Kappes K, PVI\/Seronet team, Mouhieddine TH, Wang B, Chari A, Cordon-Cardo C, Krammer F, Jagannath S, Simon V, Wajnberg A, Parekh S (2021) Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma. Cancer Cell 39(8):1028\u20131030. https:\/\/doi.org\/10.1016\/j.ccell.2021.06.014","journal-title":"Cancer Cell"},{"issue":"26","key":"5484_CR5","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1200\/JCO.21.02257","volume":"40","author":"AK Nooka","year":"2022","unstructured":"Nooka AK, Shanmugasundaram U, Cheedarla N, Verkerke H, Edara VV, Valanparambil R, Kaufman JL, Hofmeister CC, Joseph NS, Lonial S, Azeem M, Manalo J, Switchenko JM, Chang A, Linderman SL, Roback JD, Dhodapkar KM, Ahmed R, Suthar MS et al (2022) Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma. J Clin Oncol 40(26):3057\u20133064. https:\/\/doi.org\/10.1200\/JCO.21.02257","journal-title":"J Clin Oncol"},{"issue":"5","key":"5484_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/bjh.18714","volume":"201","author":"SE Faustini","year":"2023","unstructured":"Faustini SE, Hall A, Brown S, Roberts S, Hill H, Stamataki Z, (PITCH) consortium, Jenner MW, Owen RG, Pratt G, Cook G, Richter A, Drayson MT, Kaiser MF, JLJ H (2023) Immune responses to COVID-19 booster vaccinations in intensively anti-CD38 antibody treated patients with ultra-high-risk multiple myeloma: results from the Myeloma UK (MUK) nine OPTIMUM trial. Br J Haematol 201(5):845\u2013850. https:\/\/doi.org\/10.1111\/bjh.18714","journal-title":"Br J Haematol"},{"issue":"5","key":"5484_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccell.2022.03.013","volume":"40","author":"A Aleman","year":"2022","unstructured":"Aleman A, Van Oekelen O, Upadhyaya B, Beach K, Kogan Zajdman A, Alshammary H, Serebryakova K, Agte S, Kappes K, Gleason CR, Srivastava K, PVI\/MM\/Seronet Study Group, Almo S, Cordon-Cardo C, Krammer F, Merad M, Jagannath S, Wajnberg A, Simon V, Parekh S (2022) Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients. Cancer Cell 40(5):441\u2013443. https:\/\/doi.org\/10.1016\/j.ccell.2022.03.013","journal-title":"Cancer Cell"},{"issue":"8","key":"5484_CR8","doi-asserted-by":"publisher","first-page":"e764","DOI":"10.1097\/HS9.0000000000000764","volume":"6","author":"I Ntanasis-Stathopoulos","year":"2022","unstructured":"Ntanasis-Stathopoulos I, Karalis V, Gavriatopoulou M, Malandrakis P, Sklirou AD, Eleutherakis-Papaiakovou E, Migkou M, Roussou M, Fotiou D, Alexopoulos H, Theodorakakou F, Kastritis E, Iconomidou VA, Trougakos IP, Dimopoulos MA, Terpos E (2022) Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, excluding those under anti-BCMA therapy. Hemasphere 6(8):e764. https:\/\/doi.org\/10.1097\/HS9.0000000000000764","journal-title":"Hemasphere"},{"issue":"11","key":"5484_CR9","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1097\/HS9.0000000000000789","volume":"6","author":"J Salmanton-Garc\u00eda","year":"2022","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Glenth\u00f8j A, Bilgin YM, van Praet J, D\u00e1vila-Valls J, Mart\u00edn-P\u00e9rez S, Labrador J, van Doesum J, Falces-Romero I, Farina F, Sch\u00f6nlein M, Chanut M, Petzer V, Espigado I, Dargenio M, Aujayeb A, Sili U, Serrano L et al (2022) Improved clinical outcome of COVID-19 in hematologic malignancy patients receiving a fourth dose of anti-SARS-CoV-2 vaccine: an EPICOVIDEHA report. Hemasphere 6(11):e789. https:\/\/doi.org\/10.1097\/HS9.0000000000000789","journal-title":"Hemasphere"},{"issue":"5","key":"5484_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/bjh.18782","volume":"201","author":"R Suribhatla","year":"2023","unstructured":"Suribhatla R, Starkey T, Ionescu MC, Pagliuca A, Richter A, Lee LYW (2023) Systematic review and meta-analysis of the clinical effectiveness of tixagevimab\/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients. Br J Haematol 201(5):813\u2013823. https:\/\/doi.org\/10.1111\/bjh.18782","journal-title":"Br J Haematol"},{"issue":"6","key":"5484_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/s41375-023-01920-1","volume":"37","author":"E Terpos","year":"2023","unstructured":"Terpos E, Musto P, Engelhardt M, Delforge M, Cook G, Gay F, van de Donk NWCJ, Ntanasis-Stathopoulos I, Vangsted AJ, Driessen C, Schjesvold F, Cerchione C, Zweegman S, Hajek R, Moreau P, Einsele H, San-Miguel J, Boccadoro M, Dimopoulos MA et al (2023) Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN). Leukemia 37(6):1175\u20131185. https:\/\/doi.org\/10.1038\/s41375-023-01920-1","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05484-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T06:16:16Z","timestamp":1704176176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05484-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["5484"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05484-z","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}